Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03228667
Title QUILT-3.055: A Phase IIb, Single-Arm, Open-Label Study of ALT-803 in Combination With Pembrolizumab or Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Disease Progression Following an Initial Response to Treatment With PD-1 Checkpoint Inhibitor Therapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Altor Bioscience Corporation
Indications

lung non-small cell carcinoma

Therapies

ALT-803 + Nivolumab

ALT-803 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Alaska Clinical Research Center Anchorage Alaska 99530 United States Details
Genesis Cancer Center Hot Springs Arkansas 71913 United States Details
Chan Soon-Shiong Institute for Medicine El Segundo California 90245 United States Details
MemorialCare Health System Fountain Valley California 37846 United States Details
Glendale Adventist Medical Center Glendale California 91206 United States Details
University of Southern California Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Desert Hematology Oncology Medical Group, Inc. Rancho Mirage California 92270 United States Details
Memorial Healthcare System Hollywood Florida 33021 United States Details
Miami Cancer Institute (Baptist Health South Florida) Miami Florida 33176 United States Details
University of Miami Miami Florida 33180 United States Details
Horizon Oncology Associates Lafayette Indiana 47905 United States Details
University of Iowa Holden Comprehensive Cancer Center Iowa City Iowa 52242 United States Details
Baptist Health - Lexington Lexington Kentucky 40503 United States Details
Baptist Health- Louisville Louisville Kentucky 40207 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
University of Minnesota - Masonic Cancer Center Minneapolis Minnesota 55455 United States Details
Mercy Research Joplin Joplin Missouri 64804 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Mercy Clinic Cancer & Hematology - Chub O'Reilly Cancer Center Springfield Missouri 65804 United States Details
St. Vincent Frontier Cancer Center (SCL) Billings Montana 59102 United States Details
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
University of Rochester Rochester New York 14642 United States Details
Cleveland Clinic - Main Site Cleveland Ohio 44195 United States Details
Mercy Clinic Oklahoma City Oklahoma City Oklahoma 73120 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Gettysburg/Hanover Cancer Centers Gettysburg Pennsylvania 17325 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
St. Francis Cancer Center/Bon Secours St. Francis Health System Greenville South Carolina 29607 United States Details
Spartanburg Medical Center Spartanburg South Carolina 29303 United States Details
Sanford Clinical Research Sioux Falls South Dakota 57104 United States Details
University of Tennessee Medical Center Knoxville Tennessee 37920 United States Details
Oncology Consultants of Houston Houston Texas 77024 United States Details
Bon Secours Richmond Richmond Virginia 23114 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field